2021
Surveillance of adverse drug events associated with tocilizumab in hospitalized veterans with coronavirus disease 2019 (COVID-19) to inform patient safety and pandemic preparedness
Datta R, Barrett A, Burk M, Salone C, Au A, Cunningham F, Fisher A, Dembry LM, Akgün KM. Surveillance of adverse drug events associated with tocilizumab in hospitalized veterans with coronavirus disease 2019 (COVID-19) to inform patient safety and pandemic preparedness. Infection Control And Hospital Epidemiology 2021, 43: 1488-1491. PMID: 33985598, PMCID: PMC8160489, DOI: 10.1017/ice.2021.227.Peer-Reviewed Original ResearchIncreasing face-mask compliance among healthcare personnel during the coronavirus disease 2019 (COVID-19) pandemic
Datta R, Glenn K, Pellegrino A, Tuan J, Linde B, Kayani J, Patel K, Calo L, Dembry LM, Fisher A. Increasing face-mask compliance among healthcare personnel during the coronavirus disease 2019 (COVID-19) pandemic. Infection Control And Hospital Epidemiology 2021, 43: 616-622. PMID: 33938417, PMCID: PMC8144836, DOI: 10.1017/ice.2021.205.Peer-Reviewed Original Research
2020
SARS-CoV-2 detection in setting of viral swabs scarcity: Are MRSA swabs and viral swabs equivalent?
Federman DG, Gupta S, Stack G, Campbell SM, Peaper DR, Dembry LM, Fisher A, Tarabar AF, Kozal M, Ruser CB. SARS-CoV-2 detection in setting of viral swabs scarcity: Are MRSA swabs and viral swabs equivalent? PLOS ONE 2020, 15: e0237127. PMID: 32756602, PMCID: PMC7406068, DOI: 10.1371/journal.pone.0237127.Peer-Reviewed Original ResearchConceptsMRSA swabsViral swabSARS-CoV-2 PCR testingCopan ESwabSevere acute respiratory syndromeMRSA nasal swabSARS-CoV-2 assayAcute respiratory syndromeCOVID-19SARS-CoV-2SARS-CoV-2 detectionNasopharyngeal swabsCoronavirus 2Nasal swabsRespiratory syndromePCR testingSwab collectionSwabsSwab samplesCepheid Xpert XpressXpert XpressWidespread testingCollection kitHealthcare systemViral media